Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02758366
Recruitment Status : Terminated (Study was terminated due to high heterogeneity of enrolled patients)
First Posted : May 2, 2016
Last Update Posted : February 9, 2021
Sponsor:
Information provided by (Responsible Party):
Iacopo Sardi, Meyer Children's Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : January 16, 2020
Actual Study Completion Date : January 16, 2020
Publications: